Atorvastatin-mediated inhibition of prenylation of Rab27b and Rap1a in platelets attenuates their prothrombotic capacity and modulates clot structure
Open Access
- 4 May 2023
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 34 (1) , 2206921
Abstract
Statins inhibit the mevalonate pathway by impairing protein prenylation via depletion of lipid geranylgeranyl diphosphate (GGPP). Rab27b and Rap1a are small GTPase proteins involved in dense granule secretion, platelet activation, and regulation. We analyzed the impact of statins on prenylation of Rab27b and Rap1a in platelets and the downstream effects on fibrin clot properties. Whole blood thromboelastography revealed that atorvastatin (ATV) delayed clot formation time (P < .005) and attenuated clot firmness (P < .005). ATV pre-treatment inhibited platelet aggregation and clot retraction. Binding of fibrinogen and P-selectin exposure on stimulated platelets was significantly lower following pre-treatment with ATV (P < .05). Confocal microscopy revealed that ATV significantly altered the structure of platelet-rich plasma clots, consistent with the reduced fibrinogen binding. ATV enhanced lysis of Chandler model thrombi 1.4-fold versus control (P < .05). Western blotting revealed that ATV induced a dose-dependent accumulation of unprenylated Rab27b and Rap1a in the platelet membrane. ATV dose-dependently inhibited ADP release from activated platelets. Exogenous GGPP rescued the prenylation of Rab27b and Rap1a, and partially restored the ADP release defect, suggesting these changes arise from reduced prenylation of Rab27b. These data demonstrate that statins attenuate platelet aggregation, degranulation, and binding of fibrinogen thereby having a significant impact on clot contraction and structure. What is the context? What is new? What is the impact?Keywords
Funding Information
- University of Tabuk, Tabuk, Saudi Arabia
- University of Aberdeen
This publication has 55 references indexed in Scilit:
- Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2Circulation, 2012
- Distinct Roles for Rap1b Protein in Platelet Secretion and Integrin αIIbβ3 Outside-in SignalingJournal of Biological Chemistry, 2011
- Talin-dependent integrin activation is required for fibrin clot retraction by plateletsBlood, 2011
- A novel statin-mediated “prenylation block-and-release” assay provides insight into the membrane targeting mechanisms of small GTPasesBiochemical and Biophysical Research Communications, 2010
- Rab GTPases as coordinators of vesicle trafficNature Reviews Molecular Cell Biology, 2009
- Platelet α-granules: Basic biology and clinical correlatesBlood Reviews, 2009
- Enhanced nitric oxide and cyclic GMP formation plays a role in the anti‐platelet activity of simvastatinBritish Journal of Pharmacology, 2008
- Rab27b regulates number and secretion of platelet dense granulesProceedings of the National Academy of Sciences, 2007
- Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemiaThe American Journal of Cardiology, 2004
- Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995